336 related articles for article (PubMed ID: 30951791)
41. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.
Deng JH; Zhang YJ; Wang XP; Gao SJ
J Virol; 2004 Oct; 78(20):11108-20. PubMed ID: 15452231
[TBL] [Abstract][Full Text] [Related]
42. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle.
Lu CC; Li Z; Chu CY; Feng J; Feng J; Sun R; Rana TM
EMBO Rep; 2010 Oct; 11(10):784-90. PubMed ID: 20847741
[TBL] [Abstract][Full Text] [Related]
43. The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle.
Rajendren S; Ye X; Dunker W; Richardson A; Karijolich J
Nat Commun; 2023 Mar; 14(1):1367. PubMed ID: 36914661
[TBL] [Abstract][Full Text] [Related]
44. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
45. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.
Yan Q; Li W; Tang Q; Yao S; Lv Z; Feng N; Ma X; Bai Z; Zeng Y; Qin D; Lu C
PLoS One; 2013; 8(2):e55832. PubMed ID: 23418466
[TBL] [Abstract][Full Text] [Related]
46. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
[TBL] [Abstract][Full Text] [Related]
47. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
[TBL] [Abstract][Full Text] [Related]
48. A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants.
Jain V; Plaisance-Bonstaff K; Sangani R; Lanier C; Dolce A; Hu J; Brulois K; Haecker I; Turner P; Renne R; Krueger B
Viruses; 2016 Feb; 8(2):. PubMed ID: 26907327
[TBL] [Abstract][Full Text] [Related]
49. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
50. The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV.
Zhao Y; Ye X; Shehata M; Dunker W; Xie Z; Karijolich J
Nat Commun; 2020 Jul; 11(1):3345. PubMed ID: 32620802
[TBL] [Abstract][Full Text] [Related]
51. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
52. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
Katano H
Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
[TBL] [Abstract][Full Text] [Related]
53. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
[TBL] [Abstract][Full Text] [Related]
54. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
55. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
56. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
57. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
Conrad NK
Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
[TBL] [Abstract][Full Text] [Related]
58. The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation.
Alzhanova D; Meyo JO; Juarez A; Dittmer DP
J Virol; 2021 Nov; 95(23):e0145921. PubMed ID: 34523970
[TBL] [Abstract][Full Text] [Related]
59. Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.
Park MK; Cho H; Roh SW; Kim SJ; Myoung J
Sci Rep; 2019 Feb; 9(1):2372. PubMed ID: 30787356
[TBL] [Abstract][Full Text] [Related]
60. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.
Guo Y; Li W; Qin J; Lu C; Fan W
J Med Virol; 2017 Jul; 89(7):1274-1280. PubMed ID: 28165144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
